Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan Buchbinder(San Francisco Department of Public Health), Devan V. Mehrotra(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ann Duerr(Fred Hutch Cancer Center), Daniel W. Fitzgerald(Cornell University), Robin Mogg(Merck & Co., Inc., Rahway, NJ, USA (United States)), David Li(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter B. Gilbert(Fred Hutch Cancer Center), Javier R. Lama, Michael Marmor(NYU Langone Health), Carlos del Rı́o(HOPE Clinic), M. Juliana McElrath(Fred Hutch Cancer Center), Danilo R. Casimiro(Merck & Co., Inc., Rahway, NJ, USA (United States)), Keith Gottesdiener(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jeffrey Chodakewitz(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lawrence Corey(Fred Hutch Cancer Center), Michael Robertson(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 1,697Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis